Rani Therapeutics Holdings Inc. (RANI)
Market is closed
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 10,369,159 | $7,884,709 | +22% | 0.65% |
| 2. | RA Capital Management Peter Kolchinsky | 8,500,000 | $6,463,400 | 0.06% | |
| 3. | Longaeva Partners Peter Goodwin | 2,329,459 | $1,771,321 | 0.04% | |
| 4. | Siren L.L.C. Raymond Debbane | 2,000,000 | $1,520,800 | 0.03% | |
| 5. | Citadel Investment Group Ken Griffin | 641,995 | $488,173 | 0% |
Hedge Fund Resource Center